Qi, Y.-B., Li, X.-T., Shao, Q.-Q., Xu, L., Zhang, W.-J., Song, S.-B., Yan, Q.-N., Shi, S.-Y., Hu, R.-B., Mekky, A., Zhang, C., Ma, J., Xiao, W., Li, K., Liu, T.-T., Fang, X.-H., Zhang, L.-D., Yang, G.-H., & Ding, S.-Z. (2025). Vonoprazan-containing Dual and Triple Therapies are Non-inferior to Bismuth-quadruple Therapy for Helicobacter pylori Eradication: A Single-center, Prospective, Open-label, Real-World Study. Journal of Gastrointestinal and Liver Diseases, 34(3), 295–303. https://doi.org/10.15403/jgld-6183